As OVs allow for the exploitation of DAMPs and tumor antigens, inflammation induced by the adenovirus primes the tumor for subsequent DC vaccination, which elicits an anti-tumor CD8+ T-cell response in mice with lung cancer [211]. Here, CD8A is linked to neoplasm.